Alanosine

From WikiProjectMed
(Redirected from SDX-102)
Jump to navigation Jump to search
Alanosine
Skeletal formula of L-alanosine
Ball-and-stick model of the L-alanosine molecule as a zwitterion
Clinical data
ATC code
  • None
Identifiers
  • (S)-2-Amino-3-[hydroxy(nitroso)amino]propanoic acid
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC3H7N3O4
Molar mass149.106 g·mol−1
3D model (JSmol)
  • O=C(O)[C@@H](N)CN(O)N=O
  • InChI=1S/C3H7N3O4/c4-2(3(7)8)1-6(10)5-9/h2,10H,1,4H2,(H,7,8)/t2-/m0/s1 checkY
  • Key:MLFKVJCWGUZWNV-REOHCLBHSA-N checkY
  (verify)

Alanosine (also called SDX-102)[1] is a substance that has been studied for the treatment of pancreatic cancer.[2] It is an antimetabolite. It is used as one of a few experimental treatments for patients with deadly pancreatic cancer when the main chemotherapeutic treatment regimen of gemcitabine is no longer useful.[needs update]

References

  1. ^ PubChem. "Alanosine". pubchem.ncbi.nlm.nih.gov. Retrieved 2021-04-08.
  2. ^ Yu J (November 2001). "Alanosine (UCSD)". Current Opinion in Investigational Drugs. 2 (11): 1623–30. PMID 11763167.